Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Key Points

• Seven brokerages give Reckitt Benckiser a consensus recommendation of “Moderate Buy”, with analysts split as 4 holds, 1 buy and 2 strong buys; recent actions include Citigroup initiating coverage with a buy and Barclays upgrading to strong-buy while Morgan Stanley and RBC issued downgrades.
• Shares opened at $17.41, trading above the 50‑day ($16.70) and 200‑day ($15.88) moving averages with a 1‑year range of $11.99–$16.80, and the company shows a debt‑to‑equity of 1.01 with relatively tight liquidity (current ratio 0.56, quick ratio 0.37).

Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) has been given an average recommendation of "Moderate Buy" by the seven brokerages that are covering the company, Marketbeat reports. Four analysts have rated the stock with a hold rating, one has assigned a buy rating and two have issued a strong buy rating on the company.

Several brokerages have recently weighed in on RBGLY. Citigroup started coverage on shares of Reckitt Benckiser Group in a research note on Wednesday, January 14th. They set a "buy" rating for the company. Jefferies Financial Group reaffirmed a "hold" rating on shares of Reckitt Benckiser Group in a research report on Wednesday, January 7th. Barclays raised shares of Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research report on Monday, December 1st. Morgan Stanley downgraded shares of Reckitt Benckiser Group from an "overweight" rating to an "equal weight" rating in a research note on Monday, December 15th. Finally, Royal Bank Of Canada downgraded Reckitt Benckiser Group from an "outperform" rating to a "sector perform" rating in a research report on Wednesday, January 14th.

Reckitt Benckiser Group Stock Performance

RBGLY opened at $17.41 on Wednesday. The business's 50-day moving average price is $16.70 and its two-hundred day moving average price is $15.88. Reckitt Benckiser Group has a 1 year low of $11.99 and a 1 year high of $16.80. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.56 and a quick ratio of 0.37.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.

The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.